In accordance, the phosphoinositide hydrolysis pathway is also altered in AD because of reduced levels of phosphatidylinositide 3-kinase and disturbed agonist and G protein regulation of PLC [56], [57]. This evidence concerns the gene HSPG2 and Alzheimer disease.